A methylenetetrahydrofolate reductase polymorphism is associated with expression of p16 in human lung cancer

Oncology Reports

Volumn 5, Issue 4, 1998, Pages 911-914

  Kamiya, Hiroyuki ^a   Kawakami, Kazuyuki ^a   Miyanaga, Tamon ^a   Omura, Kenji ^a   Oda, Makoto ^a   Murakami, Shinya ^a   Watanabe, Yoh ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

DNA methylation; DNA stability; Lung cancer; Methylenetetrahydrofolate reductase; p16; Polymophism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); PROTEIN P16;

ADULT; AGED; ARTICLE; FOLATE METABOLISM; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG CARCINOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 0031866088     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.4.911     Document Type: Article

References (22)

1. Eto I and Krumdieck CL: Role of vitamin B12 and folate deficiencies in carcinogenesis. Adv Exp Med Biol 206: 313-330, 1986.
2. Kunz BA, Kohalmi SE, Kunkel TA, Mathews CK, McIntosh EM and Reidy JA: International Commission for Protection Against Environmental Mutagens and Carcinogens. Deoxyribonucleoside triphosphate levels: a critical factor in the maintenance of genetic stability. Mutat Res 318: 1-64, 1994.
3. Selhub J and Miller JW: The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 55: 131-138, 1992.
4. Goyette P, Sumner JS, Milos R, et al: Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification (published erratum appears in Nat Genet 7: 551, 1994). Nat Genet 7: 195-200, 1994.
5. Frosst P, Blom HJ, Milos R, et al: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase (letter). Nat Genet 10: 111-113, 1995.
6. Feinberg AP and Vogelstein B: Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301: 89-92, 1983.
7. Serrano M, Hannon GJ and Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 (see comments). Nature 366: 704-707, 1993.
8. Merlo A, Herman JG, Mao L, et al: 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers (see comments). Nat Med 1: 686-692, 1995.
9. Shapiro GI, Park JE, Edwards CD, et al: Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines. Cancer Res 55: 6200-6209, 1995.
10. Kratzke RA, Otterson GA, Lincoln CE, et al: Immunohistochemical analysis of the p16INK4 cyclin-dependent kinase inhibitor in malignant mesothelioma. J Natl Cancer Inst 87: 1870-1875, 1995.
11. Bacus JW, Hernicz RS and Bacus JV: Dual wavelength imaging microdensitometry for immunocytochemical assays in microscopy. SPIE 2622: 704-711, 1986.
12. Cravo ML, Mason JB, Dayal Y, et al: Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazine-treated rats. Cancer Res 52: 5002-5006, 1992.
13. Benito E, Obrador A, Stiggelbout A, et al: A population-based case-control study of colorectal cancer in Majorca. I. Dietary factors. Int J Cancer 45: 69-76, 1990.
14. Freudenheim JL, Graham S, Marshall JR, Haughey BP, Cholewinski S and Wilkinson G: Folate intake and carcinogenesis of the colon and rectum. Int J Epidemiol 20: 368-374, 1991.
15. Jacques PF, Boston AG, Williams RR, et al: Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93: 7-9, 1996.
16. Ma J, Stampfer MJ, Giovannucci E, et al: Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 57: 1098-1102, 1997.
17. Rusin MR, Okamoto A, Chorazy M, et al: Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers. Int J Cancer 65: 734-739, 1996.
18. Kim SK, Ro JY, Kemp BL, et al: Identification of three distinct tumor suppressor loci on the short arm of chromosome 9 in small cell lung cancer. Cancer Res 57: 400-403, 1997.
19. 1/S-regulatory genes. Mol Cell Biol 15: 4215-4224, 1995.
20. Nakagawa K, Conrad NK, Williams JP, Johnson BE and Kelley MJ: Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage. Oncogene 11: 1843-1851, 1995.
21. Caldas C, Hahn SA, da Costa LT, et al: Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma (published erratum appears in Nat Genet 8: 410, 1994). Nat Genet 8: 27-32, 1994.
22. Taga S, Osaki T, Ohgami A, et al: Prognostic value of the immunohistochemical detection of p16INK4 expression in nonsmall cell lung carcinoma. Cancer 80: 389-395, 1997.